Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer?

EduRev

All Courses

Explore Courses UPSC Exam UPSC Test Series Free Notes EduRev Infinity

Open App

CLAT Exam > CLAT Questions > Directions: Read the following passage and an...

Join the Discussion on the App

Directions: Read the following passage and answer the question.

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to the Serum Institute of India's COVID-19 vaccine Covovax and Biological E's vaccine with certain conditions, official sources said.
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.
[Source - The Print, 28 Dec, 2021]

Q. Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?

a)
Penciclovir
b)
Peramivir
c)
Molnupiravir
d)
Tamiflu

Correct answer is option 'C'. Can you explain this answer?

FREE This question is part of

Test: CLAT Mock Test - 7

Attempt Test

Attempt this Test

Most Upvoted Answer

Directions: Read the following passage and answer the question.An expe...

Molnupiravir is the first oral antiviral medication to have been approved by the UK Medicines and Healthcare Products Regulatory Agency for treating mild-to-moderate COVID-19. In India, it is authorized for production by 13 companies, but for limited use in emergency situations, primarily for adult patients with COVID-19 who are at high risk of disease progression.

Answered by Glance Learning Institute · View profile

Attention CLAT Students!

To make sure you are not studying endlessly, EduRev has designed CLAT study material, with Structured Courses, Videos, & Test Series. Plus get personalized analysis, doubt solving and improvement plans to achieve a great score in CLAT.

Legal Reasoning for CLAT

Lucent for GK

Current Affairs: Daily, Weekly & Monthly

CLAT Mock Test Series 2025

View all answers Start learning for free

< Previous Question Next Question >

Explore Courses for CLAT exam

Similar CLAT Doubts

Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.The B.1.1.529 variant, also known as Omicron, was initially brought to the attention of the World Health Organization (WHO) by which country?

View answer

Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What do coronaviruses typically cause?

View answer

Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which Article of the Indian Constitution empowers the union government to pass a law for the implementation of the International Health Regulations?

View answer

Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.What is the name of Biological Es COVID-19 vaccine?

View answer

Passage:Management is a set of processesthat can keep a complicated system of people and technology running smoothly. The most important aspects of management include planning, budgeting, organizing, staffing, controlling, and problem-solving. Leadership is a set of processes that creates organisations in the first place or adapts them to significantly changing circumstances. Leadership defines what the future should look like, aligns people with that vision, and inspires them to make it happen despite the obstacles. This distinction is absolutely crucial for our purposes here: Successful transformation is 70 to 90 per cent leadership and only 10 to 30 per cent management. Yet for historical reasons, many organisations today don‘t have much leadership. And almost everyone thinks about the problems here as one of managing change. For most of this century, as we created thousands and thousands of large organizations for the first time in human history, we didn‘t have enough good managers to keep all those burrreaucracies functioning. So many companies and universities developed management programmes, and hundreds and thousands of people were encouraged to learn management on the job. And they did. But, people were taught little about leadership. To some degree, management was emphasized because it‘s easier to teach than leadership. But even more so, management was the main item on the twentieth-century agenda because that‘s what was needed. For every entrepreneur or business builder who was a leader, we needed hundreds of managers to run their ever growing enterprises. Unfortunately for us today, this emphasis on management has often been institutionalized in corporate cultures that discourage employees from learning how to lead. Ironically, past success is usually the key ingredient in producing this outcome.The syndrome, as I have observed it on many occasions, goes like this: success creates some degree of market dominance, which in turn produces much growth. After a while keeping the ever larger organizations under control becomes the primary challenge. So attention turns inward, and managerial competencies are nurtured. With a strong emphasis on management but not on leadership, bureaucracy and an inward focus take over. But with continued success, the result mostly of market dominance, the problem often goes unaddressed and an unhealthy arrogance begins to evolve. All of these characteristics then make any transformation effort much more difficult. Arrogant managers can over- evaluate their current performance and competitive position, listen poorly, and learn slowly. Inwardly focused employees can have difficulty seeing the very forces that present threats and opportunities.Bureaucratic cultures an smother those who want to respond to shifting conditions. And the lack of leadership leaves no fore inside these organizations to break out of the morass.Q.In the passage, management is equated with

View answer

Top Courses for CLATView all

Legal Reasoning for CLAT

Lucent for GK

Current Affairs: Daily, Weekly & Monthly

CLAT Mock Test Series 2025

Crash Course for CLAT

Top Courses for CLAT

View all

Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer?

Share with a Friend

Answer this doubt

Question Description
Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? for CLAT 2024 is part of CLAT preparation. The Question and answers have been prepared according to the CLAT exam syllabus. Information about Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? covers all topics & solutions for CLAT 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer?.

Solutions for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? in English & in Hindi are available as part of our courses for CLAT. Download more important topics, notes, lectures and mock test series for CLAT Exam by signing up for free.

Here you can find the meaning of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer?, a detailed solution for Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? has been provided alongside types of Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice Directions: Read the following passage and answer the question.An expert panel of the countrys central drug authority has recommended granting emergency use authorisation to the Serum Institute of Indias COVID-19 vaccine Covovax and Biological Es vaccine with certain conditions, official sources said.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) also recommended granting permission to manufacture and market anti-Covid pill for restricted emergency use for treatment of adult patients with SpO2 93 per cent and those who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions.All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. If approved by the DCGI, the number of vaccines which have received emergency use authorisation will increase to eight. So far six COVID-19 vaccines have received emergency use authorisation from the Indian drug regulator.[Source - The Print, 28 Dec, 2021]Q.Which of the following medications has received emergency use approval in India specifically for the treatment of COVID-19 under critical circumstances?a)Penciclovirb)Peramivirc)Molnupiravird)TamifluCorrect answer is option 'C'. Can you explain this answer? tests, examples and also practice CLAT tests.

Explore Courses for CLAT exam